BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1139147)

  • 1. Neutral-lipid storage disease: a new disorder of lipid metabolism.
    Chanarin I; Patel A; Slavin G; Wills EJ; Andrews TM; Stewart G
    Br Med J; 1975 Mar; 1(5957):553-5. PubMed ID: 1139147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myopathies related to lipid metabolism disorders (review of the literature)].
    Aingorn ED; Zhurba LT; Koroleva IA; Timonina OV; Sitnikov VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1441-4. PubMed ID: 494923
    [No Abstract]   [Full Text] [Related]  

  • 3. Myopathy associated with abnormal lipid metabolism in skeletal muscle.
    Bradley WG; Hudgson P; Gardner-Medwin D; Walton JN
    Lancet; 1969 Mar; 1(7593):495-8. PubMed ID: 4179573
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutral lipid storage disease with fatty liver and cholestasis.
    Igal RA; Rhoads JM; Coleman RA
    J Pediatr Gastroenterol Nutr; 1997 Nov; 25(5):541-7. PubMed ID: 9360211
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy.
    Radom J; Salvayre R; Maret A; Nègre A; Douste-Blazy L
    Biochim Biophys Acta; 1987 Jul; 920(2):131-9. PubMed ID: 3607075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new look at the ichthyoses: disorders of lipid metabolism.
    Williams ML
    Pediatr Dermatol; 1986 Dec; 3(6):476-86. PubMed ID: 3550751
    [No Abstract]   [Full Text] [Related]  

  • 7. Multisystem triglyceride storage disease is due to a specific defect in the degradation of endocellularly synthesized triglycerides.
    Di Donato S; Garavaglia B; Strisciuglio P; Borrone C; Andria G
    Neurology; 1988 Jul; 38(7):1107-10. PubMed ID: 3386830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid storage myopathy responsive to prednisone.
    Engel AG; Siekert RG
    Arch Neurol; 1972 Aug; 27(2):174-81. PubMed ID: 5040634
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myopathies caused by defects of lipid and carbohydrate metabolism].
    Angelini C; Martinuzzi A; Micaglio G; Vergani L
    Riv Neurol; 1988; 58(1):15-25. PubMed ID: 3047844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neutral lipid storage diseases and ATGL (adipose triglyceride lipase) and CGI-58/ABHD5 (alpha-beta hydrolase domain-containing 5) deficiency: myopathy, ichthyosis, but no obesity].
    Fischer J; Negre-Salvayre A; Salvayre R
    Med Sci (Paris); 2007; 23(6-7):575-8. PubMed ID: 17631826
    [No Abstract]   [Full Text] [Related]  

  • 11. Education and imaging. Hepatology: Chanarin-Dorfman syndrome, a rare cause of fatty liver and steatohepatitis.
    Kazemi MH; Taghavi SA; Eshraghian A; Talebzadeh M; Hamidpour L
    J Gastroenterol Hepatol; 2015 May; 30(5):803. PubMed ID: 25865863
    [No Abstract]   [Full Text] [Related]  

  • 12. A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism.
    Engel WK; Vick NA; Glueck CJ; Levy RI
    N Engl J Med; 1970 Mar; 282(13):697-704. PubMed ID: 5416202
    [No Abstract]   [Full Text] [Related]  

  • 13. Dorfman-Chanarin syndrome.
    Nanda A; Sharma R; Kanwar AJ; Kaur S; Dash S
    Int J Dermatol; 1990 Jun; 29(5):349-51. PubMed ID: 2361789
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and ultrastructural features of human fibroblasts cultured from a new variant of type 3 lipid storage myopathy.
    Radom J; Salvayre R; Mussini JM; De Lisle B; Negre A; Maret A; Billaudel S; Douste-Blazy L
    Biol Cell; 1988; 62(1):39-45. PubMed ID: 3365518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorfman-Chanarin syndrome: a rare neutral lipid storage disease.
    Mitra S; Samanta M; Sarkar M; Chatterjee S
    Indian J Pathol Microbiol; 2010; 53(4):799-801. PubMed ID: 21045422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle symptoms and fat oxidation.
    Lancet; 1970 May; 1(7656):1096. PubMed ID: 4191970
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
    Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
    J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral lipid storage disease with unusual presentation: report of three cases.
    Singh S; Sharma S; Agarwal S; Nangia A; Chander R; Varghese B
    Pediatr Dermatol; 2012; 29(3):341-4. PubMed ID: 21575048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some rare congenital and metabolic myopathies.
    Walton JN
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):2-14. PubMed ID: 5293616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal mucosa in cholesterol ester storage disease. A light and electron microscope study.
    Partin JC; Schubert WK
    Gastroenterology; 1969 Nov; 57(5):542-58. PubMed ID: 5348089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.